Diabetes Mellitus, Type 2Diabetic AngiopathiesDiabetes Mellitus, Type 1Diabetes MellitusMonocytes, Activated KillerHypoglycemic AgentsHemoglobin A, GlycosylatedDiabetic NephropathiesBlood GlucoseInsulinDiabetes Mellitus, ExperimentalCross-Sectional StudiesDiabetes ComplicationsRisk FactorsCase-Control StudiesDiabetic RetinopathyDiabetes, GestationalPregnancy in DiabeticsDiabetic FootHyperglycemiaStreptozocinGlucose Tolerance TestInsulin ResistanceIslets of LangerhansDiabetic NeuropathiesObesityPrevalenceAlbuminuriaDiabetic DietGlucoseBody Mass IndexHypertensionTime FactorsPrediabetic StateMice, Inbred NODHypoglycemiaDiabetic CardiomyopathiesDiabetic KetoacidosisProspective StudiesFollow-Up StudiesInsulin-Secreting CellsC-PeptideGlucose IntoleranceCardiovascular DiseasesMetforminSulfonylurea CompoundsCohort StudiesRetrospective StudiesIncidenceFastingAlloxanBlood Glucose Self-MonitoringBiological MarkersTreatment OutcomeDiabetes InsipidusBlood PressureBody WeightReference ValuesGlutamate DecarboxylaseFructosamineGlycosuriaRisk AssessmentAge FactorsPregnancyComorbidityLipidsTriglyceridesGlycosylation End Products, AdvancedMultivariate AnalysisMetabolic Syndrome XPancreasInsulin Infusion SystemsRats, WistarSex FactorsDipeptidyl-Peptidase IV InhibitorsDisease Models, AnimalHyperlipidemiasCoronary Artery DiseaseDiabetic ComaIslets of Langerhans TransplantationKidney Failure, ChronicUnited StatesGenetic Predisposition to DiseaseJapanLogistic ModelsRegression AnalysisRats, Inbred BBOxidative StressGlucagon-Like Peptide 1ThiazolidinedionesKidneyRats, ZuckerOdds RatioDisease ProgressionDyslipidemiasRats, Sprague-DawleyPredictive Value of TestsGlucagonProportional Hazards ModelsGlucose Clamp Technique